LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of type 2 diabetes. It helps control blood sugar by increasing insulin release after meals and reducing glucose production in the liver. LINANTA 5 is commonly prescribed to improve glycemic control, support stable HbA1c levels, and help patients maintain better long-term diabetes management when combined with diet and exercise
Related products
SITPIN D 10/50
SITPIN D 10/50 contains Sitagliptin 50 mg + Dapagliflozin 10 mg, a modern combination therapy...
SITPIN 100
SITPIN 100 contains Sitagliptin 100 mg, a DPP-4 inhibitor used to manage blood sugar levels...
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
MUCINIL TAB
MUCINIL TAB contains N-Acetyl Cysteine 150 mg + Taurine 500 mg, a supportive formulation commonly...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination medicine used for managing type 2 diabetes when...
DAPAGLIDE 5
DAPAGLIDE 5 Tablet contains Dapagliflozin 5 mg, a modern anti-diabetic medicine used in the management...
CARBOSTOP 25
CARBOSTOP 25 Tablet is a combination medicine used to manage type 2 diabetes. It contains...
